<VariationArchive RecordType="classified" VariationID="66114" VariationName="NM_020988.3(GNAO1):c.572_592del (p.Thr191_Phe197del)" VariationType="Deletion" Accession="VCV000066114" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2020-10-25" MostRecentSubmission="2020-10-25">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="77011" VariationID="66114">
      <GeneList>
        <Gene Symbol="GNAO1" FullName="G protein subunit alpha o1" GeneID="2775" HGNC_ID="HGNC:4389" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="56191489" stop="56357444" display_start="56191489" display_stop="56357444" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="56225250" stop="56391355" display_start="56225250" display_stop="56391355" Strand="+" />
          </Location>
          <OMIM>139311</OMIM>
          <Haploinsufficiency last_evaluated="2022-05-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GNAO1">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-05-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GNAO1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_020988.3(GNAO1):c.572_592del (p.Thr191_Phe197del)</Name>
      <CanonicalSPDI>NC_000016.10:56334827:CCACTTCACATTCAAGAACCTCCACTTCA:CCACTTCA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16q13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="56334828" stop="56334848" display_start="56334828" display_stop="56334848" variantLength="21" positionVCF="56334827" referenceAlleleVCF="CCCACTTCACATTCAAGAACCT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="56368740" stop="56368760" display_start="56368740" display_stop="56368760" variantLength="21" positionVCF="56368739" referenceAlleleVCF="CCCACTTCACATTCAAGAACCT" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.56334836_56334856del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.56334836_56334856del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.56368748_56368768del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.56368748_56368768del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_042800.1" sequenceAccession="NG_042800" sequenceVersion="1" change="g.148498_148518del">
            <Expression>NG_042800.1:g.148498_148518del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020988.3" sequenceAccession="NM_020988" sequenceVersion="3" change="c.572_592del" MANESelect="true">
            <Expression>NM_020988.3:c.572_592del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_066268.1" sequenceAccession="NP_066268" sequenceVersion="1" change="p.Thr191_Phe197del">
            <Expression>NP_066268.1:p.Thr191_Phe197del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_138736.3" sequenceAccession="NM_138736" sequenceVersion="3" change="c.572_592del">
            <Expression>NM_138736.3:c.572_592del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_620073.2" sequenceAccession="NP_620073" sequenceVersion="2" change="p.Thr191_Phe197del">
            <Expression>NP_620073.2:p.Thr191_Phe197del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA214448" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="139311.0003" DB="OMIM" />
        <XRef Type="rs" ID="587777056" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_020988.3(GNAO1):c.572_592del (p.Thr191_Phe197del) AND Developmental and epileptic encephalopathy, 17" Accession="RCV000056407" Version="28">
        <ClassifiedConditionList TraitSetID="12020">
          <ClassifiedCondition DB="MedGen" ID="C3809606">Developmental and epileptic encephalopathy, 17</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2013-09-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2013-09-05" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-10-25" MostRecentSubmission="2020-10-25">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23993195</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="12020" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18317" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Early infantile epileptic encephalopathy 17</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 17</ElementValue>
                <XRef ID="MONDO:0014199" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DEE17</ElementValue>
                <XRef Type="MIM" ID="615473" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13378" />
                <XRef ID="13378" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="1934" DB="Orphanet" />
              <XRef ID="C3809606" DB="MedGen" />
              <XRef ID="MONDO:0014199" DB="MONDO" />
              <XRef Type="MIM" ID="615473" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="147056" SubmissionDate="2020-10-21" DateLastUpdated="2020-10-25" DateCreated="2013-10-20">
        <ClinVarSubmissionID localKey="139311.0003_DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17" title="GNAO1, 21-BP DEL, NT572_DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17" />
        <ClinVarAccession Accession="SCV000087516" DateUpdated="2020-10-25" DateCreated="2013-10-20" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-09-05">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a female infant with developmental and epileptic encephalopathy-17 (DEE17; 615473), Nakamura et al. (2013) identified a de novo identified a de novo heterozygous 21-bp deletion (c.572_592del), resulting in an in-frame deletion of 7 residues (Thr191_Phe197). The mutation was not found in the NHLBI Exome Sequencing Project database or in 408 in-house control exomes. In vitro functional expression studies in N2A cells showed that the mutant protein accumulated in the cytoplasmic compartment instead of being normally located to the cell periphery. Electrophysiologic studies in N-type calcium channels showed that the mutant protein had increased calcium-current density compared to wildtype before norepinephrine application, and showed only a mild reduction in calcium current compared to wildtype after application of norepinephrine. The findings suggested that the mutation could hamper GNAO1-mediated signaling. The patient had onset of intractable seizures at 2 weeks of age. EEG showed a burst-suppression pattern consistent with a clinical diagnosis of Ohtahara syndrome. She died at 11 months of age.</Attribute>
              <Citation>
                <ID Source="PubMed">23993195</ID>
              </Citation>
              <XRef DB="OMIM" ID="615473" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GNAO1" />
          </GeneList>
          <Name>GNAO1, 21-BP DEL, NT572</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">21-BP DEL, NT572</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="139311.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="147056" TraitType="Disease" MappingType="Name" MappingValue="DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17" MappingRef="Preferred">
        <MedGen CUI="C3809606" Name="Developmental and epileptic encephalopathy, 17" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

